204 related articles for article (PubMed ID: 12399193)
1. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
Vernacchio L; Bernstein H; Pelton S; Allen C; MacDonald K; Dunn J; Duncan DD; Tsao G; LaPosta V; Eldridge J; Laussucq S; Ambrosino DM; Molrine DC
Vaccine; 2002 Nov; 20(31-32):3658-67. PubMed ID: 12399193
[TBL] [Abstract][Full Text] [Related]
2. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Immunogenicity and Protective Efficacy of a
Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
mSphere; 2019 May; 4(3):. PubMed ID: 31043512
[No Abstract] [Full Text] [Related]
4. Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers.
Pichichero ME; Shelly MA; Treanor JJ
Pediatr Infect Dis J; 1997 Jan; 16(1):72-4. PubMed ID: 9002106
[No Abstract] [Full Text] [Related]
5. Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.
Juergens C; Trammel J; Shoji Y; Patterson S; Watson W; Webber C; Gruber WC; Scott DA; Schmoele-Thoma B
Hum Vaccin Immunother; 2018; 14(8):1948-1956. PubMed ID: 29543583
[TBL] [Abstract][Full Text] [Related]
6. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
Yang QB; Martin M; Michalek SM; Katz J
Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.
Wuorimaa T; Dagan R; Eskola J; Janco J; Ahman H; Leroy O; Käyhty H
Pediatr Infect Dis J; 2001 Mar; 20(3):272-7. PubMed ID: 11303829
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A.
Baker PJ; Hiernaux JR; Fauntleroy MB; Prescott B; Cantrell JL; Rudbach JA
Infect Immun; 1988 May; 56(5):1076-83. PubMed ID: 2965680
[TBL] [Abstract][Full Text] [Related]
11. Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
Safari D; Dekker HA; de Jong B; Rijkers GT; Kamerling JP; Snippe H
Vaccine; 2011 Sep; 29(38):6498-504. PubMed ID: 21767596
[TBL] [Abstract][Full Text] [Related]
12. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
Vandepapelière P; Rehermann B; Koutsoukos M; Moris P; Garçon N; Wettendorff M; Leroux-Roels G
Vaccine; 2005 Apr; 23(20):2591-601. PubMed ID: 15780441
[TBL] [Abstract][Full Text] [Related]
13. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
14. Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice.
Nazeri S; Zakeri S; Mehrizi AA; Djadid ND; Snounou G; Andolina C; Nosten F
Med Microbiol Immunol; 2018 Nov; 207(5-6):271-286. PubMed ID: 29948091
[TBL] [Abstract][Full Text] [Related]
15. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
16. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
Safari D; Dekker HA; Rijkers G; Snippe H
Vaccine; 2011 Jan; 29(4):849-54. PubMed ID: 21111776
[TBL] [Abstract][Full Text] [Related]
17. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
[TBL] [Abstract][Full Text] [Related]
19. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
[TBL] [Abstract][Full Text] [Related]
20. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Mazloomi E; Jazani NH; Shahabi S
Vaccine; 2012 Mar; 30(16):2640-6. PubMed ID: 22342704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
